Kalydeco just got approved to be added to the list of the Pharmaceutical Benefits Scheme (PBS) in Australia, and will become available on December 1st 2014, as announced by Australian Health Minister Pete Dutton. This means that the costs of Kalydeco will be subsidized by the Australian government, as part of its National Medicines Policy.
The Australian government is granting $174.5 million to support the supply of Kalydeco on the PBS over the next four years.
In Australia, more than 250 people suffer from the cystic fibrosis G551D gene mutation, that qualifies for treated by Kalydeco.
This is great news for our friends down-under!
Source: http://t.co/vJ7xFmPwvl
- Chris
The Australian government is granting $174.5 million to support the supply of Kalydeco on the PBS over the next four years.
In Australia, more than 250 people suffer from the cystic fibrosis G551D gene mutation, that qualifies for treated by Kalydeco.
This is great news for our friends down-under!
Source: http://t.co/vJ7xFmPwvl
- Chris